Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Office of health affairs dissolves

This article was originally published in The Gray Sheet

Executive Summary

Professional staff members from the FDA Center for Devices and Radiological Health's office of health affairs are reassigned to positions in the office of standards and regulations and the office of device evaluation following the dissolution of OHA. OHA Deputy director Thomas Arrowsmith-Lowe, MD, and staffers Peter Paras and Robert Gottesman have moved to OSR. Four staffers have moved to ODE: Kevin Mulry, DDS, to the division of general and restorative devices; Claudia Gaffey, MD, to the division of clinical laboratory devices; and Mariana Kastrinakis, MD, and Suzanne Parisian, MD, to the division of reproductive, abdominal, ENT and radiological devices. OHA Director Gordon Johnson, MD, has retired.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT000507

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel